FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that the GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes ...

W.L. Gore and Associates has announced FDA approval of the Excluder iliac branch endoprosthesis, indicated for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.

The GORE EXCLUDER Iliac Branch Endoprosthesis (IBE) is the first off-the-shelf aortic branch device approved in the U.S. and the only device indicated for the endovascular treatment of common iliac ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announced the first implants in Japan of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE). Gore has received Shonin ...

For patients with iliac artery blockages, treatment with a self-expanding stent provides better protection against restenosis at 12 months and no reduction in safety compared with a balloon-expandable ...

Background A 66-year-old man presented to hospital with gross hematuria and clots. He had previously undergone surgical repair of a right iliac artery aneurysm with placement of a vascular prosthesis ...

The IBE system provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a treatment range of 6.5-25 mm for the external iliac arteries. The delivery profile of the loaded ...